Darnestown, MD, United States of America

Ellen M Beasley

This inventor holds 195 USPTO granted patents and 5 EPO patents, primarily in Genetic Polymorphisms (CPC class C12N1-500). Top assignees: Applera Corporation, Pe Corporation (Ny), Celera Corporation. Active years: 2001-2021.


% Patents Active = 20.5

 

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 197(Granted Patents)

Forward Citations (Not Self Cited) = 182(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Darnstown, MD (US) (2002)
  • Damestown, MD (US) (2004 - 2005)
  • Rockville, MD (US) (2002 - 2006)
  • Darnestown, MD (US) (2001 - 2008)
  • Burlingame, CA (US) (2011 - 2021)

Company Filing History:


Years Active: 2001-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Genetic Polymorphisms
Psoriasis
Drug-Metabolizing Proteins
Human Kinase Proteins
Nucleic Acid Molecules
Human Protease Proteins
Human Enzyme Proteins
Human Squalene Synthase
Human G-Protein Coupled Receptors
Isolated Human Proteins
Human Phospholipase Proteins
Human Transporter Proteins
195 patents (USPTO):Explore Patents

Title: Ellen M Beasley: Pioneering Innovator in Human Genome Research

Introduction:

Ellen M Beasley is a renowned innovator and inventor based in Darnestown, MD, in the United States. With an impressive portfolio of 190 patents, Beasley has made significant contributions in the field of human genome research, with a focus on isolated human squalene synthase and G-protein coupled receptors (GPCRs). Her groundbreaking work has opened up new avenues for understanding gene expression, identifying orthologs and paralogs, and developing modulators for various enzyme peptides.

Latest Patents:

Among Beasley's recent patents, two noteworthy inventions stand out. The first is the patent for "Isolated human squalene synthase and composition thereof." This patent reveals amino acid sequences of peptides that are encoded by genes within the human genome, providing insights into the structure and function of essential enzymes. The invention includes isolated peptide and nucleic acid molecules, as well as methods of identifying orthologs, paralogs, and modulators of the enzyme peptides.

The second notable patent is for "Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof." This invention, similar in approach to the first patent, focuses on GPCR peptides encoded by genes within the human genome. It encompasses isolated peptide and nucleic acid molecules, along with methods of identifying orthologs, paralogs, and modulators of the GPCR peptides.

Career Highlights:

Throughout her career, Beasley has worked with leading companies in the industry, contributing her expertise in molecular biology and genomics. She has collaborated with Applera Corporation, renowned for its advancements in biotechnology and life sciences, and Pe Corporation (formerly known as PerkinElmer), a prominent player in genetic testing and diagnostics.

Collaborations:

Beasley's dedication and ingenuity have been complemented by successful collaborations with esteemed colleagues. Notably, she has worked closely with Valentina Di Francesco, a visionary researcher known for her work in molecular genetics, and Chunhua Yan, a distinguished scientist specializing in biochemistry and drug discovery. Together, these collaborations have resulted in fruitful insights and groundbreaking innovations.

Conclusion:

Ellen M Beasley has made substantial contributions to the field of human genome research through her numerous patents. Her inventions in isolated human squalene synthase and G-protein coupled receptors have significantly advanced our understanding of gene expression and provided valuable tools and methodologies for researchers in related fields. Beasley's impressive career and collaborations underscore her dedication to innovation and her invaluable contributions to the world of molecular biology and genomics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…